Navigation Links
Three Million Cases of Major Depressive Disorder Have Comorbid Panic Attack and Are Untreated in the U.S.
Date:9/10/2009

WALTHAM, Mass., Sept. 10 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that in the U.S., out of six million cases of major depressive disorder with comorbid panic attack, three million are untreated. Comorbid mental disorders are influential factors impacting the diagnosis and treatment of mental disorders. With this type of information drug developers can expand their markets by showing physicians that comorbid indications often go untreated.

The new report entitled Epidemiology Comorbidity Series: Cognos also finds that a diagnosed adult attention-deficit/hyperactivity disorder (ADHD) case has an 82 percent probability of being treated for ADHD when comorbid with oppositional defiant disorder and a 22 percent probability of being treated for ADHD if comorbid with nicotine dependence. This highlights that the probability of treatment of ADHD varies depending on the comorbid indication and that the comorbidity can affect and mask the diagnosis of an indication.

"Physicians may treat ADHD patients with comorbid oppositional defiant disorder more frequently because their symptoms profile is more severe," stated Donal Minihan, MVB, Ph.D., epidemiologist at Decision Resources.

Decision Resources' new Epidemiology Comorbidity Series analyzes indications and their most important comorbid disorders by effectively sizing patient populations. This series allows you to identify where opportunities for treatment lie within a given indication and comorbidity and it demonstrates how comorbid disorders can affect and mask the diagnosis of an indication.

About Decision Resources

Decision Resources (www.DecisionResources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Gisselle Morales                             Elizabeth Marshall
    Decision Resources                           Decision Resources, Inc.
    781-296-2691                                 781-296-2563
    gmorales@dresources.com                      emarshall@dresources.com


'/>"/>
SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Labopharm to present data on its novel trazodone formulation at three upcoming international medical meetings
2. Gentiva(R) Health Services Announces Appointment of Three Independent Directors
3. Three Health Institutions Join Forces to Bring World-Renowned Cancer Care to Monroe, Michigan
4. Now Three Big Losers Can Win Big With New OPTIFAST(R) Weight Loss Contest
5. Benji, Marley or Bo: Three Genes Dictate Dogs Coat
6. NewCardio Announces Master Services Agreement With Top-Three Contract Research Organization
7. DaVita to Present Three Abstracts for the International Society for Peritoneal Dialysis
8. MedNet Solutions Named to the Inc. 5000 List Three Years in a Row
9. CareTech Signs Three-Year Agreement to Provide Web Services to INTEGRIS Healths 13 Hospitals
10. Germgards New Room-Temperature Surgical Instrument Sterilizer Achieves Total Cycle Time of Three Minutes
11. Lutonix, Inc. Announces First Patient Enrollments in Three Separate Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... ... March 22, 2017 , ... An intensive search of the medical literature has ... Norins, MD, PhD. He says investigating this possibility, is important because Miami-Dade ... in new infections with HIV. , His findings appear on Analizir.com. ...
(Date:3/22/2017)... MA San Antonio, TX (PRWEB) , ... March ... ... and ISO certified medical imaging core lab with extensive therapeutic experience and operational ... a multi-year phase II immuno-oncology clinical trial for the treatment of non-small cell ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Jim ... regional families and business owners, is joining the Teen Recovery Solutions organization in ... area. , A growing number of Oklahoma teens and adolescents face problems from ...
(Date:3/22/2017)... ... 22, 2017 , ... College basketball surges to its peak during the March ... that is, recruiting people to be foster parents. Through a televised spot, Coach Self ... foster care due to abuse, neglect and other family challenges. People who respond to ...
(Date:3/22/2017)... ... ... Nearly a decade after it was first recommended that men over the ... to stir controversy. The US Preventative Services Task Force (USPSTF) issued a recommendation against ... news from a study published in JAMA Oncology suggests that more men ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... Mass. , March 22, 2017  Applied ... mechanistic modeling to drug research and development, today ... Day 2017.  QSP Day 2017 is a day ... the quantitative systems pharmacology (QSP) community. The focus ... modeling is de-risking and accelerating drug research and ...
(Date:3/22/2017)... March 22, 2017 Hologic, Inc. (Nasdaq: ... the acquisition of Cynosure, Inc., a leader in medical ... cash. "We are pleased to complete our ... Michael Davin and the entire Cynosure team ... growing medical aesthetics market," said Steve MacMillan , ...
(Date:3/22/2017)... YORK , March 22, 2017 ... (EP) market is growing rapidly due to the significant ... report published by Allied Market Research, the global electrophysiology ... expected to reach $8.271 billion by 2022, with a ... and is used to diagnose abnormal heartbeats or arrhythmia. ...
Breaking Medicine Technology: